// App-Quantinova.ai

: Efficacy and Toxicity of Donor Lymphocyte Infusions in the Management of Mixed Donor-Recipient Chimerism Following Allogeneic Stem Cell Transplantation for Lymphoid Malignancies:- a Study of the LWP-EBMT

Researchers

Presenter

  • Stephen Robinson

Principal Investigators

  • Irma Khvedelidze

  • Herv Finel

  • Karl Peggs

  • Ram K Malladi

  • Victoria Potter

  • Anna Tsoulkani

  • Elisabeth Vandenberghe

  • Yves Chalandon

  • Jrgen Finke

  • Erik Marijt

  • Sabine Furst

  • Michel Schaap

  • Hannah Hunter

  • John A Snowden

  • Karan Wadehra

  • Sebastian Wittnebel

  • Dietrich W. Beelen

  • Nathalie Fegueux

  • Nicolaus Kroeger

  • Peter Dreger

  • Silvia Montoto

Medical Centers

  • University of Bristol, Bristol, United Kingdom

  • Leukemia Working Party of EBMT, Paris, France,

  • EBMT Paris Office, Hospital Saint Antoine, Paris, France,

  • EBMT Lymphoma Working Party, Paris, France

  • Stem Cell Transplant, University College London Hospital, London, United Kingdom

  • Queen Elizabeth Hospital, Birmingham, United Kingdom

  • King's College Hosptial NHS Foundation Trust, London, United Kingdom

  • Nottingham Trent University, Nottingham, United Kingdom

  • St James Hospital and Trinity College Dublin, Dublin, IRL

  • Division of Bone Diseases, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland

  • Department of Hematology, Oncology and Stem Cell Transplantation, Uniklinik Freiburg, Freiburg, Germany

  • Leiden University, Leiden, Netherlands

  • Institut Paoli-Calmettes, Marseille, France

  • Radboud University Medical Center, Njmegen, Netherlands

  • Derriford Hospital, Plymouth, United Kingdom

  • Department of Histopathology, Leeds Teaching Hospitals NHS Foundation Trust, Leeds, United Kingdom

  • Institute Jules Bordet, Brussels, Belgium

  • Department of Bone Marrow Transplantation, University Hospital, Essen,

  • Department of Rheumatology, Lapeyronie Hospital, Montpellier, France

  • Department of Stem Cell Transplantation, University Medical Center Hamburg, Hamburg,

  • Dept. of Internal Medicine V, University Hospital Heidelberg, Heidelberg, Germany

  • Centre for Haemato-Oncology, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

Locations

  • United Kingdom

  • France

  • Switzerland

  • Germany

  • Netherlands

  • Belgium

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Genetic Disorder

Disease

  • Mantle cell lymphoma

  • Hodgkin's Lymphoma

  • T-cell lymphoma

  • Familial non-Hodgkin lymphoma

  • Lymphomas

  • Diffuse large B-cell lymphoma

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved